insights_auto
Why is REGN down 4.27%?
Dive Deeperchevron_right
REGN:NASDAQ
Regeneron Pharmaceuticals Inc
$754.41
arrow_downward
-4.27%(-33.63) 1D
Sep 28, 1:51:25 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN...
Open
$778.09
High
$780.94
Low
$750.78
Mkt. cap
77.43B
Avg. vol.
678.09K
Volume
479.74K
Dividend
0.50%
Quarterly dividend
$0.94
Ex-dividend date
Aug 18, 2026
P/E ratio
18.59
52-wk high
$859.34
52-wk low
$541.00
EPS
$40.45
Beta
0.20
Shares outstanding
101.14M
No. of employees
15K
Open
$778.09
High
$780.94
Low
$750.78
Mkt. cap
77.43B
Avg. vol.
678.09K
Volume
479.74K
Dividend
0.50%
Quarterly dividend
$0.94
Ex-dividend date
Aug 18, 2026
P/E ratio
18.59
52-wk high
$859.34
52-wk low
$541.00
EPS
$40.45
Beta
0.20
Shares outstanding
101.14M
No. of employees
15K
News stories
From web sources and news partners
AOL.com
·
33 minutes ago
Should You Buy Regeneron Pharmaceuticals Stock Before Oct. 30?
News Corp
·
1 hour ago
Inside the Eye-Drug Breakthrough That Sent Kodiak Sciences Up 172%
Benzinga
·
2 hours ago
Regeneron Eylea Feels the Pinch as Kodiak Advances Extended Dosing for Eye Drug
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc
CEOLeonard Schleifer
Employees15.3K
Founded1988
HeadquartersTarrytown, New York, United States
SectorBiotechnology
Websiteregeneron.com